Generated August 8, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
Overview
JEPI and QDTE are both equity ETFs that generate income through covered call strategies—selling call options against stock holdings to capture premium. The crucial difference: JEPI overlays calls on the S&P 500 with a 0.43 beta and a 7.64% distribution rate, while QDTE writes zero-days-to-expiration (0DTE) calls on the Nasdaq-100 with a 1.19 beta and a 23.99% distribution rate. This structural choice creates a stark tradeoff between volatility control and income frequency.
How they differ
JEPI targets large-cap stability with monthly income, while QDTE chases weekly income through aggressive daily option rolls on growth-heavy tech stocks. JEPI's 0.43 beta signals it dampens broad market swings; QDTE's 1.19 beta amplifies Nasdaq-100 moves. The income gap is enormous: QDTE's 23.99% distribution rate is more than triple JEPI's 7.64%, but that high yield depends on continuous rolling of expiring options, not underlying capital appreciation. QDTE costs 0.95% annually versus JEPI's 0.35%, and QDTE is much newer (March 2024 inception versus May 2020) with $963M in AUM compared to JEPI's $45.8B. JEPI uses equity-linked notes structured into the fund; QDTE writes 0DTE calls directly—a more transparent but operationally intensive approach that resets daily rather than monthly.
Who each is best for
JEPI: Fits investors seeking moderate equity exposure with regular monthly payouts and material downside cushion, who can tolerate call-writing's opportunity cost if the underlying rallies sharply.
QDTE: Designed for tactically oriented investors comfortable with Nasdaq-100 concentration and volatility, who prioritize immediate cash flow and understand that extreme distribution rates depend on persistent option premium availability.
Key risks to know
- NAV erosion at extreme distribution yields. QDTE's 23.99% annual payout rate likely exceeds the underlying Nasdaq-100's long-term return potential, meaning NAV is likely to erode over time unless rolling call premiums offset that shortfall—a reliance that weakens if market volatility falls or if tech call premiums compress.
- Call capping during rallies. Both funds sacrifice upside if the underlying index rallies past call strike prices. QDTE's weekly rolls and higher tech beta mean capped gains occur more frequently and often coincide with periods when investors most want index participation.
- 0DTE structural concentration risk in QDTE. Rolling calls daily against Nasdaq-100 exposure concentrates duration risk into a single day's expiration and leaves the fund sensitive to gap risk at market open or close; a single disruptive earnings report or geopolitical event could spike IV and leave QDTE's positions underwater before the new roll.
- Volatility dependence. Both funds' option premiums depend on implied volatility. A sustained drop in equity market turbulence would compress call prices and reduce future distributions below current rates, hitting QDTE harder given its reliance on daily rolls.
- Nasdaq-100 tech concentration in QDTE. Unlike JEPI's S&P 500 breadth, QDTE's underlying is tilted toward mega-cap technology. Concentration risk overlaps with options risk if a tech sector downturn coincides with a volatility decline that crushes option premiums.
Bottom line
JEPI suits investors who want a lower-volatility equity income stream with a reasonable payout and room for capital appreciation; QDTE suits those who prioritize maximum cash flow and can tolerate tech sector concentration and the probability of NAV decline over time. The 23.99% yield is compelling on paper but reflects weekly option rolls rather than underlying business growth, so it cannot persist indefinitely at that rate. Neither strategy amplifies absolute returns—both rely on premium capture and opportunity costs inherent to covered calls.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.